English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
Advanced prostate cancer has an unexpected weakness that can be targeted by drugs
Advanced prostate cancer has an unexpected weakness that can be targeted by drugs
Imaging technique could replace tissue biopsies in assessing drug resistance in cancer
Imaging technique could replace tissue biopsies in assessing drug resistance in cancer
EBCC-12: HER2  breast cancer patients live longer if drugs given before surgery eradicate tumour
EBCC-12: HER2 breast cancer patients live longer if drugs given before surgery eradicate tumour
Breast cancer medication risk: Beta-blockers linked to lower survival in some patients
Breast cancer medication risk: Beta-blockers linked to lower survival in some patients
ESMO 2020: 20-year research breakthrough offers new hope for breast cancer patients
ESMO 2020: 20-year research breakthrough offers new hope for breast cancer patients
Gut microbiome may influence how cancer patients respond to oral therapies
Gut microbiome may influence how cancer patients respond to oral therapies
ESMO 2020: Two-pronged attack using new targeted drug could treat ‘addicted’ prostate cancers
ESMO 2020: Two-pronged attack using new targeted drug could treat ‘addicted’ prostate cancers
ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer
ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer
ESMO 2020: First new drug in years reduces recurrence in high-risk hormone receptor positive early breast cancer
ESMO 2020: First new drug in years reduces recurrence in high-risk hormone receptor positive early breast cancer
Innovative, minimally invasive treatment can help maintain prostate cancer patients' quality of life
Innovative, minimally invasive treatment can help maintain prostate cancer patients' quality of life
<1...5657585960...105>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top